Patents by Inventor Ana Pereda-Lopez

Ana Pereda-Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
    Patent number: 8263558
    Abstract: The subject invention relates to the cloning, expression and isolation of recombinant forms of beta-amyloid protein containing a N-terminal methionine (or one or more amino acids) as well as to methods of using this recombinant protein in the production of therapeutic antibodies, in the identification of therapeutic small molecules, and in the performance of diagnostic assays.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: September 11, 2012
    Assignees: Abbott Laboratories, Abbott GmbH & Co. KG
    Inventors: Thomas F. Holzman, John E. Harlan, Rohinton P. Edalji, Edward T. Olejniczak, Ana Pereda-Lopez, Boris Labkovsky, Liping Yu, Heinz Hillen, Stefan Barghorn, Ulrich M. Ebert
  • METHODS OF PREPARATION OF RECOMBINANT FORMS OF HUMAN BETA-AMYLOID PROTEIN AND USES OF THESE PROTEINS
    Publication number: 20090214515
    Abstract: The subject invention relates to the cloning, expression and isolation of recombinant forms of beta-amyloid protein containing a N-terminal methionine (or one or more amino acids) as well as to methods of using this recombinant protein in the production of therapeutic antibodies, in the identification of therapeutic small molecules, and in the performance of diagnostic assays.
    Type: Application
    Filed: November 30, 2006
    Publication date: August 27, 2009
    Inventors: Thomas F. Holzman, John E. Harlan, Rohinton P. Edalji, Edward T. Olejniczak, Ana Pereda-Lopez, Boris Labkovsky, Liping Yu, Heinz Hillen, Stefan Barghorn, Ulrich M. Ebert
  • Novel polyketide derivatives and recombinant methods for making same
    Publication number: 20030013662
    Abstract: The invention provides novel erythromycin derivatives in which methyl groups on the macrolactone ring have been substituted with —H, -Et, and/or —OH. The invention also provides reagents such as isolated polynucleotides, vectors comprising the polynucleotides and host cells transformed with the vectors for making the novel compounds. Methods for making the compounds utilizing genetic engineering techniques are also disclosed.
    Type: Application
    Filed: December 11, 2000
    Publication date: January 16, 2003
    Inventors: Leonard Katz, Diane L. Stassi, Richard G. Summers, Xiaoan Ruan, Ana Pereda-Lopez, Stephan J. Kakavas
  • Polyketide derivatives and recombinant methods for making same
    Patent number: 6200813
    Abstract: The invention provides novel erythromycin derivatives in which methyl groups on the macrolactone ring have been substituted with —H, -Et, and/or —OH. The invention also provides reagents such as isolated polynucleotides, vectors comprising the polynucleotides and host cells transformed with the vectors for making the novel compounds. Methods for making the compounds utilizing genetic engineering techniques are also disclosed.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: March 13, 2001
    Assignee: Abbott Laboratories
    Inventors: Leonard Katz, Diane L. Stassi, Richard G. Summers, Jr., Xiaoan Ruan, Ana Pereda-Lopez, Stephan J. Kakavas
  • Polyketide derivatives and recombinant methods for making same
    Patent number: 6063561
    Abstract: The invention provides novel erythromycin derivatives in which methyl groups on the macrolactone ring have been substituted with --H, -Et, and/or --OH and the ethyl side-chain has been substituted with hydroxymethyl or dihydroxycyclohexylmethyl side-chains. The invention also provides reagents such as isolated polynucleotides, vectors comprising the polynucleotides and host cells transformed with the vectors for making the novel compounds. Methods for making the compounds utilizing genetic engineering techniques are also disclosed.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: May 16, 2000
    Assignee: Abbott Laboratories
    Inventors: Leonard Katz, Diane L. Stassi, Richard G. Summers, Jr., Xiaoan Ruan, Ana Pereda-Lopez, Stephan J. Kakavas
  • Polyketide derivatives and recombinant methods for making same
    Patent number: 6060234
    Abstract: The invention provides novel erythromycin derivatives in which methyl groups on the macrolactone ring have been substituted with --H, --Et, and/or --OH. The invention also provides reagents such as isolated polynucleotides, vectors comprising the polynucleotides and host cells transformed with the vectors for making the novel compounds. Methods for making the compounds utilizing genetic engineering techniques are also disclosed.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: May 9, 2000
    Assignee: Abbott Laboratories
    Inventors: Leonard Katz, Diane L. Stassi, Richard G. Summers, Jr., Xiaoan Ruan, Ana Pereda-Lopez, Stephan J. Kakavas